Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Dedicated to enhancing knowledge and skill in the care of the allergic patient."

ADVOCACY UPDATES

Your AAOA at the AMA

I want to urge you to consider membership in the AMA because your membership in…

read more

Fall Advocacy Update: USP 797, E/M Documentation and Payment

Revisions to USP Chapter 797 Open for Comment Since the United States Pharmacopeia (USP) released…

read more

Brief Update on the Final CY 2019 Physician Fee Schedule

On November 1, the Centers for Medicare and Medicaid Services released the final Physician Fee…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

12/01/2018: Research Grant Cycle
Learn more

04/01/2019: 2019 Fellow Exam Application Deadline
Learn more

06/01/2019: Research Grant Cycle

06/7/19: Membership Application Deadline to be eligible for AAOA Member rate for the 2019 Basic Course

07/31/19: Membership Application Deadline to be voted in at the 2019 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2019 Annual Meeting
Learn more

EDUCATION

Codes/Guidelines

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

IFAR

IFAR Impact Factor: 2.135

aaoaf-ifar

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2019 Interactive Allergy & Rhinology Course
February 8-10, 2019 | Dallas, TX
Learn More and Register

2019 Basic Course in Allergy & Immunology
June 27-29 | Minneapolis, MN
Save the Date

2019 AAOA Annual Meeting
September 13-15 | New Orleans, LA
Save the Date

2019 Advanced Course in Allergy & Immunology
December 12-14 | Austin, TX
Save the Date

AAOA Clinical Insights
Learn More and Register

PATIENT CORNER

OTC Allergy Medications

There seem to be more and more medications available for allergy treatment that  you can now purchase over the counter.
The FDA is allowing previously prescription only drugs to be made available directly to the consumer without a prescription — adding more to the over-the-counter options in the healthcare aisles.

Read More

News and Updates

From the AAOA President, Matthew Ryan, MD

...the AAOA continues to be the organization that Otolaryngologists look to for up-to-date education and information on the…

read more

FDA Approves First Generic Version of EpiPen

The Food and Drug Administration approves the first generic version of EpiPen and EpiPen Jr.…

read more

Social and Networking Events at the 2018 AAOA Annual Meeting

This year’s Annual Meeting assures to be not only educational, interactive, and practice-centered, but also…

read more

Menu
Scope

President’s Message: Five Items AAOA Members Need to Know 2017

  1. MACRA  (Medicare Access and CHIP Reauthorization Act) is different from ACA (Affordable Care Act)

    Most of the quality and EMR measures initially listed in the ACA, such as Meaningful Use, are being replaced by Quality Payment Programs (QPP) such as MIPS.  While politics are difficult to predict and there are calls to repeal and replace ACA, physicians will still likely be affected by MACRA and its QPPs.  Physician data collection for MACRA began in 2017.  The AAOA will strive to keep our members up to date and provide useful links to resources.  A good place to start is CMS for the unfamiliar.

  2. How do members get more involved?

    1. Become an AAOA Fellow.
    2. Submit for Research Grants.
    3. Submit an Instruction Course for the Annual Meeting (Deadline March 1st).
    4. Participate in AAOA Committees. Visit Our Join or About pages.
  3. What is the AAOA Leadership working on?

    • Our digital platform is in its early years and we are looking for the best ways to create and deliver.
    • We are working on a large literature review on Allergic Rhinitis (ICAR) for our journal which will serve as an excellent reference for our members.
    • Our social media presence has increased recently; follow the AAOA on Twitter (link).
    • Redesign of MOC/Core Basic Meeting into the more interactive Allergy /Rhinology Course.
    • The Annual Meeting continues to be modified to be more valuable to our members.
    •  The IFAR journal continues to grow with higher metrics of reputation and new Podcasts that have proved popular.
  4. There continues to be issues with allergy mixing included in more stringent compounding regulation.

    Regulations prompted by infections complications from spine and joint injections affect the AAOA and our friends in Allergy Immunology and other ENT sub-specialties.  The AAOA is actively working with other professional societies to educate the FDA and pharmacist organizations about the exceptional low risk of infection from allergy immunotherapy and the importance of not creating unnecessary barriers to access.   Large responses to surveys and requests for public comments have been very helpful in our advocacy of safe, accessible, and personalized immunotherapy.

  5. Allergy and Sinus Codes are in different phases of review.

    The AAOA will continue to work with other societies, including the AAO-HNS and the AMA, to provide informed decision-making as codes are reviewed.  AAOA members’ co-membership in the AAO-HNS and the AMA are essential to provide a greater political voice in valuation of codes.

AAOA staff, volunteer leadership, and members continue to work together on array of issues that directly impact our member’s practices.  It is an important time to be an active AAOA member.

Join or Renew Today

Whit Mims, MD

AAOA President

Leave a Reply

Your email address will not be published. Required fields are marked *